至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination

Biomaterials. 2018; 
Uchida S, Yoshinaga N, Yanagihara K, Yuba E, Kataoka K, Itaka K.
Products/Services Used Details Operation
Gene Synthesis … pCI-neo-sOVA (soluble ovalbumin) plasmid (#25098, Addgene, Cambridge, MA, USA) [29] was codon-optimized by GenScript Japan (Tokyo, Japan) to remove BsmBI recognition site, then inserted into a pT7-pA-SP6 vector to create pT7-OVA-pA-SP6, a template DNA for OVA … Get A Quote

摘要

Messenger (m)RNA vaccines require a safe and potent immunostimulatory adjuvant. In this study, we introduced immunostimulatory properties directly into mRNA molecules by hybridizing them with complementary RNA to create highly immunogenic double stranded (ds)RNAs. These dsRNA formulations, comprised entirely of RNA, are expected to be safe and highly efficient due to antigen expression and immunostimulation occurring simultaneously in the same antigen presenting cells. In this strategy, design of dsRNA is important. Indeed, hybridization using full-length antisense (as)RNA drastically reduced translational efficiency. In contrast, by limiting the hybridized portion to the mRNA poly A region, efficient translati... More

关键词